| The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin P Quintana, M Ventura, M Grifell, A Palma, L Galindo, I Fornís, C Gil, ... International Journal of Drug Policy 40, 78-83, 2017 | 98 | 2017 |
| Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells L Galindo, E Moreno, F López-Armenta, D Guinart, A Cuenca-Royo, ... Molecular neurobiology 55, 6347-6361, 2018 | 47 | 2018 |
| Patterns of use and toxicity of new para‐halogenated substituted cathinones: 4‐CMC (clephedrone), 4‐CEC (4‐chloroethcatinone) and 4‐BMC (brephedrone) M Grifell, M Ventura, X Carbón, P Quintana, L Galindo, Á Palma, I Fornis, ... Human Psychopharmacology: Clinical and Experimental 32 (3), e2621, 2017 | 47 | 2017 |
| Default mode network aberrant connectivity associated with neurological soft signs in schizophrenia patients and unaffected relatives L Galindo, D Bergé, GK Murray, A Mané, A Bulbena, V Pérez, O Vilarroya Frontiers in Psychiatry 8, 298, 2018 | 41 | 2018 |
| Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services PE Oomen, D Schori, K Tögel-Lins, D Acreman, S Chenorhokian, A Luf, ... International Journal of Drug Policy 100, 103493, 2022 | 39 | 2022 |
| Something new about something old: a 10-year follow-up on classical and new psychoactive tryptamines and results of analysis ÁJ Palma-Conesa, M Ventura, L Galindo, F Fonseca, M Grifell, ... Journal of Psychoactive Drugs 49 (4), 297-305, 2017 | 26 | 2017 |
| Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use D Guinart, E Moreno, L Galindo, A Cuenca-Royo, M Barrera-Conde, ... Schizophrenia Bulletin 46 (6), 1547-1557, 2020 | 24 | 2020 |
| Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives L Galindo, F Pastoriza, D Bergé, A Mané, M Picado, A Bulbena, ... PeerJ 4, e1651, 2016 | 22 | 2016 |
| Opioid addiction: short-and long-acting opioids M Torrens, F Fonseca, L Galindo, M Farré Textbook of addiction treatment: International perspectives, 467-500, 2015 | 18 | 2015 |
| Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS N La Maida, M Pellegrini, E Papaseit, C Pérez-Mañá, L Poyatos, ... International journal of molecular sciences 21 (24), 9414, 2020 | 17 | 2020 |
| Acute pharmacological effects and oral fluid biomarkers of the synthetic cannabinoid UR-144 and THC in recreational users NL Maida, E Papaseit, L Martínez, C Pérez-Mañá, L Poyatos, M Pellegrini, ... Biology 10 (4), 257, 2021 | 14 | 2021 |
| Cannabis use induces distinctive proteomic alterations in olfactory neuroepithelial cells of schizophrenia patients M Barrera-Conde, K Ausin, M Lachén-Montes, J Fernández-Irigoyen, ... Journal of personalized medicine 11 (3), 160, 2021 | 14 | 2021 |
| Acute pharmacological effects and oral fluid concentrations of the synthetic cannabinoids JWH-122 and JWH-210 in humans after self-administration: an observational study L Martínez, N La Maida, E Papaseit, C Pérez-Mañá, L Poyatos, ... Frontiers in Pharmacology 12, 705643, 2021 | 11 | 2021 |
| Addiction to Hallucinogens Dissociatives, Designer Drugs and “Legal Highs” M Farré, L Galindo, M Torrens Textbook of Addiction Treatment: International perspectives, N. El-Guebaly …, 2014 | 11 | 2014 |
| Effects of cannabis use on the protein and lipid profile of olfactory neuroepithelium cells from schizophrenia patients studied by synchrotron-based FTIR spectroscopy S Saladrigas-Manjón, T Dučić, L Galindo, C Fernández-Avilés, V Pérez, ... Biomolecules 10 (2), 329, 2020 | 8 | 2020 |
| A trip to the unknown: 2, 5-dimethoxy-4-chloroamphetamine (DOC) sold as LSD: study on samples delivered by users asking for substance analysis M Grifell, A Palma, M Ventura, I Fornís, F Dinamarca, M Torrens, ... Eur Neuropsychopharmacol 25, S620, 2015 | 5 | 2015 |
| Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis CMJ Wannan, B Nelson, J Addington, K Allott, A Anticevic, C Arango, ... Schizophrenia bulletin 50 (3), 496-512, 2024 | 4 | 2024 |
| 25I-NBOMe: the legal LSD I Ezquiaga, M Grifell, L Galindo, L Martínez, Á Palma, P Quintana, ... European Psychiatry 33 (S1), S72-S73, 2016 | 4 | 2016 |
| The synthetic cannabinoids: JWH, four years of analysis L Galindo, M Grifell, P Quintana, A Palma, J Tirado, M Ventura, I Fornis, ... European Psychiatry 33 (S1), S115-S116, 2016 | 4 | 2016 |
| Influence of time to clozapine prescription on the clinical outcome LI Muñoz-Manchado, JI Perez-Revuelta, A Banerjee, L Galindo-Guarin, ... Schizophrenia Research 268, 189-192, 2024 | 3 | 2024 |
